FinServ Acquisition Corp. Files $200 Million SPAC
by Kristi Marvin on 2019-10-14 at 1:50pm

Late Friday evening, we had a second SPAC file for IPO with FinServ Acquisition Corp. (FSRVU).  FinServ is a $200 million financial services and fintech-focused SPAC being led by Lee Einbinder, who is the former Vice Chairman of Barclays.  Mr. Einbinder, who recently retired from Barclays in August of this year, will be CEO and Director of FinServ, along with Howard Kurz, as President and CFO.

However, this is mostly a former Lehman Brothers team, with Mr. Einbinder, Mr. Kurz, Robert Matza (a Director of FinServ) and Diane Glossman (also a Director of FinServ) having all worked at Lehman previously. Additionally, Barclays, which as we all know bought Lehman Brother during the financial crisis, will be left lead underwriter. This is Barclays’s second SPAC this year (and ever) having previously book-run Tortoise Acquisition Corp. (SHLL), this past March. However, Barclays will also be joined by Cantor, as joint book-runner, providing additional SPAC underwriting experience.

Additionally, while the FinServ team does not have prior SPAC experience, they do have an Advisor to this team that does, with Shami Patel. Mr. Patel, who is a Managing Director of the Asset Management Group of Cohen & Co., was a Director, Chair of the Audit Committee and member of the Compensation Committee of FinTech I and FinTech II. So while Mr. Patel is not part of the team proper, having him as an Advisor is a nice extra.

So clearly FinServ has the right background for a financial services/fintech SPAC.  However, what about the structure?  Well, FinServ is a 100% in trust, 24 months, 1/2 a warrant SPAC.  Again, similar to Osprey Technology, where in a different SPAC climate they might have tried for a 1/3 warrant (regardless of SPAC experience), they’re opting for the 1/2 warrant instead, which is an easier sell.  As a result, this SPAC should have no trouble rounding out their book.  It’s a good match of terms and team.

Lastly, the FinServ filing makes it eight on file to IPO, which, if all eight price this year, the count for 2019 will be 50 SPACs total.  That’s four more than 2018’s 46 SPACs.  Furthermore, it also means SPACs will potentially raise north of $11.4 billion in gross proceeds. Although, those numbers are likely to be much higher since we still have plenty of room this year for additional SPACs to file. Regardless, what this means is, 2019 is already going to be a record breaking year for the SPAC asset class (post-financial crisis).

Look for FinServ to price on a similar schedule to Osprey Technology – very late October (October 31st?) or early November.

Summary of terms below:

FinServ Summary of terms 10-14-19

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved